REITs invest in the majority of real estate property types, including offices, apartment buildings, warehouses, retail centers, medical facilities, data centers, cell towers and hotels.
Nareit’s REIT Directory provides a comprehensive list of REIT and publicly traded real estate companies that are members of Nareit. The directory can be sorted and filtered by sector, listing status, and stock performance.
Each year Nareit collects tax reporting data for each Nareit member. View this year's data or explore the archive.
REITs delivered strong investment performance through mid-year 2026, outperforming the broad equity market by a sizable margin.
The REIT industry's premier annual conference, bringing together leaders for networking, one-on-one meetings, and insights shaping the year ahead.
For 65 years, Nareit has led the U.S. REIT industry by ensuring its members’ best interests are promoted by providing unparalleled advocacy, investor outreach, continuing education and networking.
CEO James Taylor points to shortage of new supply in the open air segment.
CEO Rick Matros says tenants do not have to repay the REIT until they see returns.
Tamara Fischer sees supply remaining muted into 2024.
CEO Dan Oberste also says millennials and gen z comprise largest cohort of REIT’s tenant base.
Chatham Financial’s Gavin Duckworth sees transition from LIBOR to SOFR.
Michael Kessler also says M&A conditions remain favorable.
Natalie Teear of Hudson Pacific Properties says that high industry greenhouse gas emissions are leading to increased action.
Ed Fritsch was the recipient of Nareit’s 2023 Industry Leadership Award.
Brent Smith said REIT is seeing strong pick up in leasing from smaller tenants.
Lisa Palmer says REIT industry is recognizing that increasing diversity is a joint effort.
CEO Andrew Spodek said the REIT has 6% of total USPS market share and is just “getting started.”
Palmer, CEO of Regency Centers Corp., said she also looks to continue Nareit’s momentum of a strong reputation and presence on Capitol Hill.
Co-President Dean Shigenaga says strong bipartisan support for NIH funding is essential.